Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Merck & Co. describes new somatostatin sst5 receptor antagonists

Dec. 9, 2010

Prochieve 8% reduces incidence of preterm birth in phase III study

Dec. 7, 2010

Forest Laboratories discloses novel acetyl-CoA carboxylase inhibitors

Dec. 7, 2010

Case Western Reserve University licenses insulin analogues to Thermalin Diabetes

Dec. 7, 2010

Novartis claims new inhibitors of sodium/glucose cotransporters

Dec. 3, 2010

Spanish scientists patent new bivalent pyrazole derivatives

Dec. 3, 2010

Roche divulges new inhibitors of beta-secretase 2

Dec. 2, 2010

Roche claims new isoquinoline derivatives

Dec. 2, 2010

Pronova BioPharma describes new lipid molecules

Dec. 2, 2010

Health Canada approves velaglucerase alfa for type I Gaucher's disease

Dec. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.